Fear of Movement and Catastrophizing in Participants with Temporomandibular Disorders

Häggman‐Henrikson, Birgitta; Jawad, Nora; Acuña, Xochitl Mena; Visscher, Corine M.; Schiffman, Eric L; List, Thomas

doi:10.11607/ofph.3060

Cited by 16 publications

(16 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…First, the improvement of all variables related to the mandibular range of motion was significant only 180 days after treatment, while a significant improvement in the muscle sensibility to palpation was observed already 28 days after treatment. These findings are understandable since it is well-known that pain can restrict movements, whether by kinesiophobia and/or muscle protective contraction [ 25 , 26 , 27 , 28 ]. Therefore, it is expected that the mandibular range of motion only improves after a significant reduction of muscle sensibility.…”

Section: Discussionmentioning

confidence: 95%

Efficacy of Botulinum Toxin Type-A I in the Improvement of Mandibular Motion and Muscle Sensibility in Myofascial Pain TMD Subjects: A Randomized Controlled Trial

Canales

Poluha

Pinzón

et al. 2022

Toxins

View full text Add to dashboard Cite

This study assessed the effects of botulinum toxin type A (BoNT-A) in mandibular range of motion and muscle tenderness to palpation in persistent myofascial pain (MFP) patients (ReBEC RBR-2d4vvv). Eighty consecutive female subjects with persistent MFP, were randomly divided into four groups (n = 20): three BoNT-A groups with different doses and a saline solution group (placebo control group). Treatments were injected bilaterally in the masseter and anterior temporalis muscle in a single session. Clinical measurements of mandibular movements included: pain-free opening, maximum unassisted and assisted opening, and right and left lateral excursions. Palpation tests were performed bilaterally in the masseter and temporalis muscle. Follow-up occurred 28 and 180 days after treatment. For the statistical analysis the Mann–Whitney U-test with Bonferroni correction was used for groups comparisons. Regardless of dose, all parameters of mandibular range of motion significantly improved after 180 days in all BoNT-A groups, compared with the control group. Palpation pain over the masseter and temporalis muscles were significantly reduced in all BoNT-A groups regardless of dose, compared with the control group, after 28 and 180 days of treatment. Independent of doses, BoNT-A improved mandibular range of motion and muscle tenderness to palpation in persistent MFP patients.

show abstract

Section: Discussionmentioning

confidence: 95%

Efficacy of Botulinum Toxin Type-A I in the Improvement of Mandibular Motion and Muscle Sensibility in Myofascial Pain TMD Subjects: A Randomized Controlled Trial

Canales

Poluha

Pinzón

et al. 2022

Toxins

View full text Add to dashboard Cite

show abstract

“…First, the improvement of all variables related to the mandibular range of motion was significant only 180 days after treatment, while a significant improvement in the muscle sensibility to palpation was observed already 28 days after treatment. These findings make sense since it is well known that pain can restrict movements, whether by kinesiophobia and/or muscle protective contraction [22][23][24][25] . Therefore, it is expected that the mandibular range of motion only improves after a significant reduction of muscle sensibility.…”

Section: Discussionmentioning

confidence: 99%

Does Botulinum Toxin Type–a Improve Mandibular Motion and Muscle Sensibility in Myofascial Pain Tmd Subjects? A Randomized, Controlled Clinical Trial

Poluha¹,

Rizzatti-Barbosa²,

Pinzón³

et al. 2022

Preprint

View full text Add to dashboard Cite

To demonstrate if botulinum toxin type A (BoNT-A) improves mandibular range of motion and muscle sensibility to palpation in refractory myofascial pain (MFP) patients. METHODS: Eighty consecutive female subjects with refractory MFP, were randomly divided into four equal groups (n=20): BoNT-A low (BoNTA-L/10 U in each temporalis and 30 U in each masseter), BoNT-A medium (BoNTA-M/20 U in each temporalis and 50 U in each masseter), BoNT-A high (BoNTA-H/25 U in each temporalis and 75 U in each masseter) and saline solution 0.9% (SS, placebo control group/0.4 mL in each temporalis and 0.6 mL in each masseter). Clinical measurements of the mandibular movements included: pain-free opening, maximum unassisted and assisted opening, and right and left lateral movements. Palpation tests were performed bilaterally in masseter and temporalis muscle. Results were expressed as median, minimum, maximum, and means ± standard deviation (SD). Chi-Square Test was used to compare differences among groups. A 5% probability level was considered significant in all tests RESULTS: Regardless of dose, all parameters of mandibular range of motion significantly improve after 180 days in BoNT- A groups, when compared to the control group. Pain to palpation on muscles, significantly reduced in all BoNT- A groups regardless of dose, when compared to the control group, after 28 and 180 days of treatment. CONCLUSIONS: Independent of doses, BoNT-A improved mandibular range of motion and muscle sensibility to palpation in refractory MFP patients when compared to SS injections.

show abstract

“…A high level of physical symptoms as a predictor for the development of jaw pain is in line with previous studies where both psychological distress and physical symptoms were reported as risk factors for jaw pain [ 31 , 32 ]. In addition, individuals with TMD show higher levels of physical symptoms when compared to controls [ 33 ]. Physical symptoms were also a risk factor for incident TMD regardless of whether pain was included as a physical symptom or not [ 9 ].…”

Section: Discussionmentioning

confidence: 99%

Whiplash trauma did not predict jaw pain after 2 years: an explorative study

Böthun,

Lövgren,

Stålnacke

et al. 2024

Clin Oral Invest

Self Cite

View full text Add to dashboard Cite

Objectives To explore predictive factors for the development and maintenance of jaw pain over a 2-year period. Methods One hundred nineteen cases (73 women) and 104 controls (59 women), mean age 34.9 years (SD 13.9), attended baseline and 2-year follow-up examinations. The whiplash cases visited the emergency department at Umeå University Hospital, Sweden, with neck pain within 72 h following a car accident, and baseline questionnaires were answered within a month after trauma. Controls were recruited via advertising. Inclusion criteria were age 18–70 years, living in Umeå municipality and Swedish speaking. The exclusion criterion was neck fracture for cases and a previous neck trauma for controls. Validated questionnaires recommended in the standardized Research Diagnostic Criteria for temporomandibular disorders were used. Jaw pain was assessed by two validated screening questions answered with “yes” or “no.” A logistic regression analysis was used to predict the outcome variable jaw pain (yes/no) after 2 years. Results Whiplash trauma did not increase the odds of development of jaw pain over a 2-year period (OR 1.97, 95% CI 0.53–7.38). However, non-specific physical symptoms (OR 8.56, 95% CI 1.08–67.67) and female gender (OR 4.89, 95% CI 1.09–22.02) did increase the odds for jaw pain after 2 years. Conclusion The development and maintenance of jaw pain after whiplash trauma are primarily not related to the trauma itself, but more associated with physical symptoms. Clinical relevance The development of jaw pain in connection with a whiplash trauma needs to be seen in a biopsychosocial perspective, and early assessment is recommended.

show abstract

Fear of Movement and Catastrophizing in Participants with Temporomandibular Disorders

Cited by 16 publications

References 0 publications

Efficacy of Botulinum Toxin Type-A I in the Improvement of Mandibular Motion and Muscle Sensibility in Myofascial Pain TMD Subjects: A Randomized Controlled Trial

Efficacy of Botulinum Toxin Type-A I in the Improvement of Mandibular Motion and Muscle Sensibility in Myofascial Pain TMD Subjects: A Randomized Controlled Trial

Does Botulinum Toxin Type–a Improve Mandibular Motion and Muscle Sensibility in Myofascial Pain Tmd Subjects? A Randomized, Controlled Clinical Trial

Whiplash trauma did not predict jaw pain after 2 years: an explorative study

Contact Info

Product

Resources

About